FDA weak on off-label marketing enforcement; Scientist predicts stem-cell revolution;

> It looks like the FDA is doing a lousy job of enforcing its rules on off-label marketing of prescription drugs, according to a new report. FiercePharma

> A scientist working with stem cells is predicting that they are the next revolution--and that they'll have as big an impact on 21st century medicine as antibiotics did in the 20th century. FierceBioResearcher

> A state contractor tampered with Maryland's cancer registry, counting hundreds of patients as having cancer when they did not, in an effort to make sure the database met national certification standards. Article

> While hospitals in many regions are frustrated with their progress, execs seem more optimistic in Indianapolis, where facilities have invested more than $1 billion to build more facilities since 2000. Article

And Finally... And I thought having two or three children was a lot of work. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.